Publications

National decision-making on adopting new vaccines: a systematic review.

BURCHETT, HE D; MOUNIER-JACK, S; GRIFFITHS, UK; MILLS, AJ;

2011

Health policy and planning, (2011).27 Sup suppl 10.1093/heapol/czr049.

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.

Olotu, A; Lusingu, J; Leach, A; Lievens, M; Vekemans, J; Msham, S; Lang, T; Gould, J; Dubois, M-C; Jongert, E; Vansadia, P; Carter, T; Njuguna, P; Awuondo, KO; Malabeja, A; Abdul, O; Gesase, S; Mturi, N; DRAKELEY, CJ; Savarese, B; Villafana, T; Lapierre, D; Ballou, WR; Cohen, J; Lemnge, MM; ... Bejon, P.

2011

The Lancet infectious diseases, (2011).11 2 10.1016/S1473-3099(10)70262-0.

Protection against malaria by MSP3 candidate vaccine.

Sirima, SB; COUSENS, S; Druilhe, P;

2011

The New England journal of medicine, (2011).365 11 10.1056/NEJMc1100670.

Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months.

Russell, FM; Balloch, A; Licciardi, PV; Carapetis, JR; Tikoduadua, L; Waqatakirewa, L; Cheung, YB; MULHOLLAND, EK; Tang, ML K;

2011

Vaccine, (2011).29 27 10.1016/j.vaccine.2011.04.038.

BCG vaccination: a role for vitamin D?.

Lalor, MK; FLOYD, S; GORAK-STOLINSKA, P; Weir, RE; BLITZ, R; BRANSON, K; FINE, PE; DOCKRELL, HM;